BioCentury
ARTICLE | Company News

PGNX, UR Labs in licensing deal

October 1, 2001 7:00 AM UTC

Progenics (PGNX) received an exclusive worldwide license from UR Labs (Chicago, Ill.) to methylnaltrexone (MNTX), an opioid receptor antagonist in Phase II testing to treat opioid-induced constipation...